June 4, 2024 09:36 AM EDTUpdated June 5, 12:03 PM

Updated: What the first five participants for FDA's Operation Warp Speed for rare diseases are tackling

Zachary Brennan

Senior Editor

FDA’s biologics chief Peter Marks famously coined the first race to the Covid-19 vaccine as Operation Warp Speed. Now the second iteration of OWS is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Updated: What the first five participants for FDA's Operation Warp Speed for rare diseases are tackling

Zachary Brennan

Senior Editor

Sign up to read this article for free.

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

Updated: Eli Lilly wins long-awaited approval for Alzheimer’s drug

Flagship appears to boost target of eighth fund by up to $500M

Why the Supreme Court's overrule of Chevron has major implications for the FDA

Experts want to make it easier to get RSV vaccines. Did they make it harder instead?

As confidence falls, biopharma companies take precautions with Chinese partnerships, survey finds

Up­dat­ed: What the first five par­tic­i­pants for FDA's Op­er­a­tion Warp Speed for rare dis­eases are tack­ling

Zachary Brennan

Senior Editor

Sign up to read this article for free.

more like this

In biotech's un­even re­cov­ery, 50 star­tups raised megarounds in first half of 2024

Up­dat­ed: Eli Lil­ly wins long-await­ed ap­proval for Alzheimer’s drug

Flag­ship ap­pears to boost tar­get of eighth fund by up to $500M

Why the Supreme Court's over­rule of Chevron has ma­jor im­pli­ca­tions for the FDA

Ex­perts want to make it eas­i­er to get RSV vac­cines. Did they make it hard­er in­stead?

As con­fi­dence falls, bio­phar­ma com­pa­nies take pre­cau­tions with Chi­nese part­ner­ships, sur­vey finds

Updated: What the first five participants for FDA's Operation Warp Speed for rare diseases are tackling

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

Updated: Eli Lilly wins long-awaited approval for Alzheimer’s drug

Flagship appears to boost target of eighth fund by up to $500M

Why the Supreme Court's overrule of Chevron has major implications for the FDA

Experts want to make it easier to get RSV vaccines. Did they make it harder instead?

As confidence falls, biopharma companies take precautions with Chinese partnerships, survey finds